Advertisement
Screener

REDHILL BIOPHARMA LTD. (RDHL) Form 6-K: Report of foreign private issuer

REDHILL BIOPHARMA LTD. Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2026-09-01: Form 6-K; Period of report 2026-09-01; Description 6-K; Document zk2636058.htm.
  • 2026-08-31: Form 6-K; Period of report 2026-08-31; Description 6-K; Document zk2636045.htm.
  • 2026-08-07: Form 6-K; Period of report 2026-08-07; Description 6-K; Document zk2635830.htm.
  • 2026-08-06: Form 6-K; Period of report 2026-08-06; Description 6-K; Document zk2635829.htm.
FiledFormPeriod of reportDescriptionDocument
2026-09-016-K2026-09-016-Kzk2636058.htm
2026-08-316-K2026-08-316-Kzk2636045.htm
2026-08-076-K2026-08-076-Kzk2635830.htm
2026-08-066-K2026-08-066-Kzk2635829.htm
2026-07-286-K2026-07-286-Kzk2635740.htm
2026-07-016-K2026-07-016-Kzk2635629.htm
2026-06-296-K2026-06-296-Kzk2635622.htm
2026-06-256-K2026-06-256-Kzk2635602.htm
2026-06-226-K2026-06-226-Kzk2635593.htm
2026-06-226-K2026-06-226-Kzk2635591.htm
2026-06-226-K2026-06-226-Kzk2635581.htm
2026-06-186-K2026-06-186-Kzk2635574.htm
2026-06-096-K2026-06-096-Kzk2635520.htm
2026-06-086-K2026-06-086-Kzk2635511.htm
2026-06-026-K2026-06-026-Kzk2635461.htm
2026-05-276-K2026-05-276-Kzk2635182.htm
2026-04-306-K2026-04-306-Ka2635158.htm
2026-04-276-K2026-04-276-Kzk2635135.htm
2026-04-226-K2026-04-226-Kzk2635114.htm
2026-04-146-K2026-04-146-Kzk2635072.htm
2026-03-056-K2026-03-056-Kzk2634498.htm
2026-02-256-K2026-02-256-Kzk2634440.htm
2026-01-276-K2026-01-276-Kzk2634252.htm
2026-01-226-K2026-01-226-Kzk2634241.htm
2026-01-056-K2026-01-056-Kzk2634180.htm